结构-活动关系和对PSMA-617及其衍生品的生物洞察与修饰的脂性链接器区域的生物洞察
Martin Schäfer1, Ulrike Bauder-Wüst2, Mareike Roscher1
1Service Unit for Radiopharmaceuticals and Preclinical Studies, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
ACS omega
|March 3, 2025
概括
PSMA-617类型的结构-活性关系揭示了左侧灵活性,并指导了新型前列腺特异性膜抗原 (PSMA) 向前列腺癌 (PCa) 向剂的设计.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 放射性药物化学 放射性药物化学
背景情况:
- 前列腺特异性膜抗原 (PSMA) 向放射性核素治疗是前列腺癌 (PCa) 的关键治疗方法.
- PSMA-617是一种基准配体,广泛用于PCa治疗.
- 了解结构-活动关系 (SAR) 对于开发改进的PSMA准剂至关重要.
研究的目的:
- 调查PSMA-617和两种新型类型 (P17,P18) 具有修饰链接器的SAR.
- 通过晶体结构阐明PSMA腔内的结合相互作用和链接器灵活性.
- 为了评估新类型的药物的功效,细胞吸收和体内生物分布.
主要方法:
- 新型PSMA配体P17和P18的合成和表征.
- 用X射线晶体学来确定PSMA的复杂结构,使用PSMA-617,P17和P18.
- 在体外测定PSMA抑制,细胞结合和内部化.
- 在相关模型中的体内生物分布研究.
主要成果:
- PSMA/PSMA-617复合体的晶体结构显示出一个折叠的链接体形状.
- PSMA/P17和PSMA/P18复合体表现出扩展的左侧方向,表明左侧灵活性.
- 相似的P17和P18保持了高PSMA抑制,细胞结合和内部化,与PSMA-617相比.
- 在体内研究显示,所有化合物的瘤吸收都相似,P18增加了脏积累.
结论:
- 在PSMA类似物中的链接器修改会影响PSMA腔内的结合形状和灵活性.
- 观察到的SAR为下一代PSMA向神经毒剂的结构导向设计提供了一个框架.
- 新的类型证明了改善前列腺癌治疗的潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.5K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.5K


